Pfizer's COVID-19 vaccine to have differential pricing: CEO
Pfizer's CEO Albert Bourla said the company will have differential pricing on its COVID-19 vaccine for different countries. "We are having a tier-based pricing. It is one price for the developed world based on their GDP and a lower price for the middle-income countries," he said. "In low-income countries like Africa, we're giving it on a no-profit basis," he added.